Scientific research in universities is funded through a mix of public money, EU funding and other sources. This article considers the House of Lords Science and Technology Committee report on the pressures on science research funding in universities, including proposals in the Augar Review to lower the existing cap on tuition fees and the potential impact of Brexit. The committee’s report is due to debated in the House of Lords on 9 September 2020.

This article looks at the current candidates for a Covid-19 vaccine, focusing on the University of Oxford/AstraZeneca project, and the Moderna candidate from the US National Institute of Allergy and Infectious Diseases. The article highlights the new mRNA technology being developed in some projects. It also looks at what the Government is doing to support vaccine development.